SPDR Advertisement SureTrader SureTrader SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 7/1/2015 11:27:44 PM - Followers: 1232 - Board type: Free - Posts Today: 0
PostSubject
#193103  Sticky Note NTRA (Natera) IPOs 11.5M* shares @$18.00: DewDiligence 07/01/15 09:21:38 PM
#193097  Sticky Note SGYP: There is a new article from Seeking iandy 07/01/15 04:55:12 PM
#193090  Sticky Note Hedgefund short EXAS seeks CMS restrictions on Cologuard reimbursement: DewDiligence 07/01/15 10:48:42 AM
#193087  Sticky Note XENE -22% on failed phase-2b in osteoarthritis: DewDiligence 07/01/15 10:19:09 AM
#193082  Sticky Note Cholesterol control and diabetes risk: iwfal 07/01/15 12:55:34 AM
#193043  Sticky Note Re: CELG-JUNO deal arithmetic DewDiligence 06/29/15 06:30:38 PM
#193105   Hedgefund short EXAS seeks CMS restrictions on Cologuard drbio45 07/01/15 11:27:44 PM
#193104   XENE - 7/1/15 CC notes mcbio 07/01/15 10:30:55 PM
#193103   NTRA (Natera) IPOs 11.5M* shares @$18.00: DewDiligence 07/01/15 09:21:38 PM
#193102   GILD—I wonder why they chose to use the DewDiligence 07/01/15 09:08:02 PM
#193101   RE: GILD HIV ciotera 07/01/15 06:33:13 PM
#193100   IART spins off spinal-fusion business: DewDiligence 07/01/15 05:51:53 PM
#193099   GILD submits NDA for TAF/Emtiva/Edurant FDC*, using priority-review voucher: DewDiligence 07/01/15 05:02:08 PM
#193098   XNCR—The guest presentation by Dr Tyler Curiel of DewDiligence 07/01/15 04:56:00 PM
#193097   SGYP: There is a new article from Seeking iandy 07/01/15 04:55:12 PM
#193096   ENTA's new CMO (not CSO). Her résumé is DewDiligence 07/01/15 04:47:42 PM
#193095   ENTA- FWIW, new CSO receives "welcome aboard" 90,000 biotech_researcher 07/01/15 04:19:20 PM
#193094   "A total of 3472 drugs were Orphan drug Bickema 07/01/15 02:54:37 PM
#193093   NVO pulls Trehsiba from Germany due to insufficient price: DewDiligence 07/01/15 02:28:25 PM
#193091   Nice move.solid news.solid balance sheet,cash =$ 45.7 -link back ash111 07/01/15 01:39:55 PM
#193090   Hedgefund short EXAS seeks CMS restrictions on Cologuard reimbursement: DewDiligence 07/01/15 10:48:42 AM
#193089   BXLT—pharma spin-off from BAX—launches as independent company: DewDiligence 07/01/15 10:24:48 AM
#193088   (TCON)—Santen files IND for DE-122 in wet AMD: DewDiligence 07/01/15 10:22:43 AM
#193087   XENE -22% on failed phase-2b in osteoarthritis: DewDiligence 07/01/15 10:19:09 AM
#193086   Roche/EXEL—FDA extends PDUFA to 11/11/15 for Cobimetinib sNDA DewDiligence 07/01/15 10:13:05 AM
#193085   DDXS implements 1:15 reverse split: DewDiligence 07/01/15 10:10:44 AM
#193084   REPH sells 1.38M shares @$11.60 in private placement: DewDiligence 07/01/15 10:07:31 AM
#193083   $DVAX Analyst Rating Update: The higher and the whatisthecolorofmone 07/01/15 07:19:52 AM
#193082   Cholesterol control and diabetes risk: iwfal 07/01/15 12:55:34 AM
#193081   …based on the cited ADXS anal-cancer drug efficacy, DewDiligence 06/30/15 09:12:50 PM
#193080   What I do know is, based on the mcbio 06/30/15 08:48:20 PM
#193079   Israeli start-up freezes breast cancer in its tracks, Preciouslife1 06/30/15 06:51:08 PM
#193078   Roche/Evotec’s Sembragiline fails phase-2b in AD: DewDiligence 06/30/15 03:41:10 PM
#193077   Implication of the Juno Celgene Deal for Emerging maverick_1 06/30/15 02:07:56 PM
#193076   SNSS in breakout mode. Has closed above cakesgood 06/30/15 01:16:43 PM
#193075   Yes correct masterlongevity 06/30/15 12:15:02 PM
#193074   NVS considering novel pricing schemes for Entresto (LCZ696): DewDiligence 06/30/15 11:58:51 AM
#193073   Rarely would these comparative trials use the linhdtu 06/30/15 11:47:41 AM
#193072   BIIB gets 30% [of US sales of Ocrelizumab]If DewDiligence 06/30/15 11:47:12 AM
#193071   BIIB gets 30% masterlongevity 06/30/15 11:39:22 AM
#193070   MCRB > Repeated courses of antibiotics may profoundly biocqr 06/30/15 11:36:30 AM
#193069   Roche/BIIB—Ocrelizumab bested Rebif in two phase-3 trials in DewDiligence 06/30/15 11:24:42 AM
#193068   Medivir doing early-stage R&D on nuke for HCC, DewDiligence 06/30/15 11:12:37 AM
#193067   CRMD down 22% in the past week mr_o 06/30/15 11:08:22 AM
#193066   Oh, it was more than a nice try. Fred Kadiddlehopper 06/30/15 10:56:46 AM
#193065   Same as Roche and FMI.However there is the linhdtu 06/30/15 10:22:52 AM
#193064   I have seen anecdotal posts with positive info willyw 06/30/15 10:20:20 AM
#193063   Way to be spot on! KingDMC 06/30/15 10:09:48 AM
#193062   It was clear from the PR that CELG zipjet 06/30/15 10:05:42 AM
#193061   Mr Mkt seems to agree with Dew. lol linhdtu 06/30/15 09:57:18 AM
#193060   JUNO—lol nice try. Why do you think JUNO DewDiligence 06/30/15 09:56:04 AM
#193059   Still love the potential but pricing is very disappointing ronpopeil 06/30/15 09:53:25 AM
#193058   Background of ENTA’s new CMO: DewDiligence 06/30/15 09:46:36 AM
#193057   AbbVie (NYSE:ABBV) shares ended sharply lower on Monday Bickema 06/30/15 09:37:13 AM
#193056   PIRS > prices @ 18% discount....Pieris Pharma Prices biocqr 06/30/15 09:23:59 AM
#193055   Enanta Pharmaceuticals Announces the Appointment of Nathalie Adda, caravon 06/30/15 09:17:54 AM
PostSubject